{"id":20847,"date":"2022-03-15T21:41:00","date_gmt":"2022-03-15T13:41:00","guid":{"rendered":"http:\/\/www.accunome.com.cn\/accunome-sciences-was-ranked-as-one-of-the-top-50-most-promising-startups-in-2021-by-silicon-valley-media-the-information\/"},"modified":"2022-06-04T19:09:29","modified_gmt":"2022-06-04T11:09:29","slug":"accunome-sciences-was-ranked-as-one-of-the-top-50-most-promising-startups-in-2021-by-silicon-valley-media-the-information","status":"publish","type":"post","link":"http:\/\/www.accunome.com.cn\/en\/accunome-sciences-was-ranked-as-one-of-the-top-50-most-promising-startups-in-2021-by-silicon-valley-media-the-information\/","title":{"rendered":"Accunome Sciences was Ranked As one of \u201cThe Top 50 Most Promising Startups in 2021\u201c by Silicon Valley media &#8220;The Information&#8221;"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"20847\" class=\"elementor elementor-20847 elementor-19435\" data-elementor-settings=\"[]\">\n\t\t\t\t\t\t<div class=\"elementor-inner\">\n\t\t\t\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3bde7b82 elementor-section-boxed elementor-section-height-default elementor-section-height-default sc_fly_static\" data-id=\"3bde7b82\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-extended\">\n\t\t\t\t\t\t\t<div class=\"elementor-row\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5e93fd9e sc_inner_width_none sc_content_align_inherit sc_layouts_column_icons_position_left sc_fly_static\" data-id=\"5e93fd9e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-column-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-585eb433 sc_fly_static elementor-widget elementor-widget-text-editor\" data-id=\"585eb433\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-text-editor elementor-clearfix\">\n\t\t\t\t<p><span class=\"trx_addons_dropcap trx_addons_dropcap_style_2\"><strong>R<\/strong><\/span><strong>ecently, The Information, a leading high tech media in Silicon Valley, released their \u201cThe 50 Most Promising Startups of 2021\u201dwhich includes 50 startup companies with high growth potential worldwide. Due to the rise of outstanding Chinese companies in the high tech industry, The Information created a separate \u201cChina\u201d section this year. Accunome Sciences is one of the seven companies listed in the\u201cChina\u201d section.<\/strong><\/p><p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-19732\" src=\"http:\/\/web.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-1.png\" alt=\"\" width=\"866\" height=\"604\" srcset=\"http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-1.png 866w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-1-300x209.png 300w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-1-768x536.png 768w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-1-370x258.png 370w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-1-840x586.png 840w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-1-410x286.png 410w\" sizes=\"auto, (max-width: 866px) 100vw, 866px\" \/><\/p><p><strong>The information evaluates Accunome as follows:<\/strong><\/p><p>Accunome is trying to become one of the domestic pioneers in the field of testing patients for infectious disease using molecular diagnostics\u2014tests that examine genomes. The field is still relatively new in China\u2019s medical sector. Western medical diagnostics conglomerates make such tests, but their presence is limited in China because of regulatory hurdles and meeting Chinese hospital labs\u2019 expectations for low prices. Accunome says its diagnostic instruments and test kits allow hospitals to conduct automated tests without the need to hire specially trained staff. The company says its instruments have fulfilled local requirements in China and it expects to obtain final regulatory approval by the end of this year. Profit margins are slim for such instruments, but diagnostic companies usually make a bigger profit by selling test kits that must be used with the instruments\u2014similar to a razor and blade business model. Accunome says it is aiming to launch its first test kit, for influenza, by the end of 2022 after completing a clinical trial that will likely take about six months.<\/p><p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-19733\" src=\"http:\/\/web.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-2.png\" alt=\"\" width=\"866\" height=\"983\" srcset=\"http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-2.png 866w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-2-264x300.png 264w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-2-768x872.png 768w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-2-370x420.png 370w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-2-840x953.png 840w, http:\/\/www.accunome.com.cn\/wp-content\/uploads\/2022\/03\/4-2-410x465.png 410w\" sizes=\"auto, (max-width: 866px) 100vw, 866px\" \/><\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Recently, The Information, a leading high tech media in Silicon Valley, released their \u201cThe 50 Most Promising Startups of 2021\u201dwhich includes 50 startup companies with high growth potential worldwide. Due&hellip;<\/p>\n","protected":false},"author":1,"featured_media":20730,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[191],"tags":[],"class_list":["post-20847","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/posts\/20847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/comments?post=20847"}],"version-history":[{"count":2,"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/posts\/20847\/revisions"}],"predecessor-version":[{"id":21013,"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/posts\/20847\/revisions\/21013"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/media\/20730"}],"wp:attachment":[{"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/media?parent=20847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/categories?post=20847"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.accunome.com.cn\/en\/wp-json\/wp\/v2\/tags?post=20847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}